Gil Tauber

Efficacy of Vismodegib for the Treatment of Orbital and Advanced Periocular Basal Cell Carcinoma.

A. Priel, G. B. Ben simon, A. A. Elkader, 2019, American journal of ophthalmology.

Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma.

E. Hodak, J. Alcalay, E. Fenig, 2015, Journal of drugs in dermatology : JDD.

Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp.

E. Hodak, E. Fenig, L. Pavlovsky, 2015, Journal of the American Academy of Dermatology.

Gene-Related Response of Basal Cell Carcinoma to Biologic Treatment with Vismodegib

J. Béjar, N. Goldenberg-Cohen, H. Shefer, 2020, Scientific Reports.